Order Article Reprints

Fernández-Gómez I, Sablón-Carrazana M, Bencomo-Martínez A, Domínguez G, Lara-Martínez R, Altamirano-Bustamante NF, Jiménez-García LF, Pasten-Hidalgo K, Castillo-Rodríguez RA, Altamirano P, et al. Diabetes Drug Discovery: hIAPP_1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets. Molecules. 2018; 23(3):686. https://doi.org/10.3390/molecules23030686

Fernández-Gómez, Isaac, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Guadalupe Domínguez, Reyna Lara-Martínez, Nelly F. Altamirano-Bustamante, Luis Felipe Jiménez-García, Karina Pasten-Hidalgo, Rosa Angélica Castillo-Rodríguez, Perla Altamirano, and et al. 2018. "Diabetes Drug Discovery: hIAPP_1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets" Molecules 23, no. 3: 686. https://doi.org/10.3390/molecules23030686

Fernández-Gómez, I., Sablón-Carrazana, M., Bencomo-Martínez, A., Domínguez, G., Lara-Martínez, R., Altamirano-Bustamante, N. F., Jiménez-García, L. F., Pasten-Hidalgo, K., Castillo-Rodríguez, R. A., Altamirano, P., Marrero, S. R., Revilla-Monsalve, C., Valdés-Sosa, P., Salamanca-Gómez, F., Garrido-Magaña, E., Rodríguez-Tanty, C., & Altamirano-Bustamante, M. M. (2018). Diabetes Drug Discovery: hIAPP_1–37 Polymorphic Amyloid Structures as Novel Therapeutic Targets. Molecules, 23(3), 686. https://doi.org/10.3390/molecules23030686